Search Results
Jun 30, 2026, 12:00 ET Erasca, Inc. (ERAS) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
ERAS).
More news about: Glancy Prongay Wolke & Rotter LLP
Jun 29, 2026, 16:15 ET Your Travel Day Super Hero Has Arrived: CLEAR Teams Up with Marvel Animation's "X-Men '97" Season 2 to Help Members Win the Day of Travel
a 99% on Rotten Tomatoes as of today."X-Men '97" Season 2 continues with the heroic mutant team of X-Men, divided and thrown across different eras in time as they struggle to navigate their return home. Meanwhile, back in the 1990s, suspicious foes and new strains of mutant intolerance are on the
More news about: CLEAR
Jun 29, 2026, 15:36 ET Erasca, Inc. (ERAS) Faces Securities Class Action Amid Patient Death, Intellectual Property Questions, $2.8 Billion Market Cap Loss -- HBSS
compared the equivalence of its ERAS-0015 40 milligram dose cohort to RevMed's RMC-6236 400 milligram dose cohort. In addition, as recently as March 12, 2026, Erasca allegedly assured investors of its ERAS-0015 intellectual property protection, and touted that its ERAS-0015 has "in-licensed one
More news about: Hagens Berman Sobol Shapiro LLP
Jun 26, 2026, 22:00 ET Erasca Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Erasca - ERAS
Erasca, Inc. (NasdaqGS: ERAS) ("Erasca" or the "Company"), if they purchased or otherwise acquired the Company's securities between January 14, 2025 and April 26, 2026, inclusive
More news about: ClaimsFiler
Jun 26, 2026, 14:45 ET Erasca, Inc. (ERAS) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
ERAS). IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN ERASCA, INC. (ERAS), CONTACT THE LAW OFFICES OF HOWARD G. SMITH BEFORE AUGUST 10, 2026 (LEAD PLAINTIFF DEADLINE)
More news about: Law Offices of Howard G. Smith
Jun 25, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Erasca, Inc. of Class Action Lawsuit and Upcoming Deadlines - ERAS
market hours on April 27, 2026, Erasca reported preliminary Phase 1 clinical data for ERAS-0015 and disclosing that one patient that received 24 mg of ERAS-0015 had died approximately a month after starting ERAS-0015. The patient was classified as a "Grade 3 TRAE of pneumonitis" that "progressed to Grade
More news about: Pomerantz LLP
Jun 25, 2026, 09:00 ET Erasca, Inc. (ERAS) Faces Securities Class Action Amid Patient Death, Intellectual Property Questions, $2.8 Billion Market Cap Loss -- HBSS
compared the equivalence of its ERAS-0015 40 milligram dose cohort to RevMed's RMC-6236 400 milligram dose cohort. In addition, as recently as March 12, 2026, Erasca allegedly assured investors of its ERAS-0015 intellectual property protection, and touted that its ERAS-0015 has "in-licensed one
More news about: Hagens Berman Sobol Shapiro LLP
Jun 24, 2026, 10:07 ET ERAS Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Erasca, Inc. Securities Lawsuit - Contact Levi & Korsinsky
previously undisclosed patient death in the ERAS-0015 Phase 1 trial. The window to apply for lead plaintiff closes on August 10, 2026.Notice to Institutional HoldersPension funds, mutual funds, endowments, and asset managers that acquired ERAS shares during the Class Period face potential
More news about: Levi & Korsinsky, LLP
Jun 24, 2026, 09:04 ET Michaels® Unveils 2026 Halloween Décor Collections Inspired by the Magic of Halloweens Past
with the unveiling of its largest and most diverse Halloween assortment to date, featuring six distinct collections inspired by the iconic aesthetics, eras, and cultural touchstones of Halloweens past. From vintage carnival mysticism to roller-rink nostalgia, witchy coming-of-age tales and the dark romance
More news about: The Michaels Companies, Inc.
Jun 23, 2026, 15:19 ET Erasca, Inc. (ERAS) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
ERAS) have opportunity to lead the securities fraud class action lawsuit.
More news about: The Law Offices of Frank R. Cruz, Los Angeles
Jun 23, 2026, 14:28 ET HMH Donates Historic Artwork to Northeast Museums
rich and diverse history of picture book art.""HMH played an essential role in the history of American illustration, commissioning many of the era's most distinguished artists and bringing their work to broad audiences," said Thomas Padon, the James H. Duff Director of the Brandywine Museum of Art.
More news about: HMH Education Company
Jun 23, 2026, 12:15 ET INVESTOR ALERT: Erasca, Inc. (ERAS) Investors with Substantial Losses Have Opportunity to Lead the Erasca Class Action Lawsuit
reported preliminary Phase I clinical data for ERAS-0015 and disclosed that one patient who received 24 mg of ERAS-0015 had died approximately one month after starting ERAS-0015. Erasca allegedly further disclosed that comparisons between ERAS-0015 and other product candidates were based
More news about: Robbins Geller Rudman & Dowd LLP
Jun 23, 2026, 11:53 ET Erasca, Inc. (ERAS) Faces Securities Class Action Amid Patient Death, Intellectual Property Questions, $2.8 Billion Market Cap Loss -- HBSS
compared the equivalence of its ERAS-0015 40 milligram dose cohort to RevMed's RMC-6236 400 milligram dose cohort. In addition, as recently as March 12, 2026, Erasca allegedly assured investors of its ERAS-0015 intellectual property protection, and touted that its ERAS-0015 has "in-licensed one
More news about: Hagens Berman Sobol Shapiro LLP
Jun 23, 2026, 10:02 ET The Gross Law Firm Reminds Erasca, Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of August 10, 2026 - ERAS
June 23, 2026 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Erasca, Inc. (NASDAQ: ERAS).
More news about: The Gross Law Firm
Jun 23, 2026, 06:18 ET Fair Play Menarini International Award
football, will be honored. Nicknamed "El Buitre", Butragueño was the symbol of Real Madrid in the 1980s and a key figure in one of the most successful eras in the history of the Madrid club.With the addition of Milito and Butragueño, the list of awardees of the 30th Fair Play Menarini International
More news about: Menarini Industrie Farmaceutiche Riunite
Jun 23, 2026, 06:15 ET Fair Play Menarini International Award
football, will be honored. Nicknamed "El Buitre", Butragueño was the symbol of Real Madrid in the 1980s and a key figure in one of the most successful eras in the history of the Madrid club.With the addition of Milito and Butragueño, the list of awardees of the 30th Fair Play Menarini International
More news about: Menarini Industrie Farmaceutiche Riunite
Jun 22, 2026, 04:30 ET Erasca, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - ERAS
ERAS) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of ERAS during the class period listed are encouraged
More news about: DJS Law Group LLP
Jun 21, 2026, 20:27 ET ERAS Investors Have Opportunity to Lead Erasca, Inc. Securities Fraud Lawsuit
federal securities laws by making false and misleading statements about its lead oncology drug candidate, ERAS-0015, throughout the Class Period. According to the complaint, Erasca repeatedly touted ERAS-0015 as a potential "best-in-class" therapy and highlighted purportedly superior preclinical results compared
More news about: THE ROSEN LAW FIRM, P. A.
Jun 19, 2026, 22:00 ET Erasca, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
Erasca, Inc. ("Erasca" or the "Company") (NasdaqGS: ERAS) of a class action securities lawsuit.
More news about: Kahn Swick & Foti, LLC
Jun 19, 2026, 11:00 ET OCAD University represents Canada at Gwangju Biennale 2026, one of the world's most important contemporary art exhibitions
significance and international exchange projects, the museum operates various exhibitions and cultural education programs that bridge generations and eras. Since 2018, in collaboration with the Gwangju Biennale, it has organized exhibitions of the Philippines National Pavilion and the Canadian National
More news about: OCAD University
Jun 19, 2026, 09:00 ET Erasca, Inc. (ERAS) Faces Securities Class Action Amid Patient Death, Intellectual Property Questions, $2.8 Billion Market Cap Loss -- HBSS
/PRNewswire/ -- Erasca, Inc. (NASDAQ: ERAS) faces a securities class action after the stock tanked $9.25 (-48%) on news that Revolution Medicines (RevMed) accused Erasca of patent infringement concerning Erasca's pan-RAS molecular glue targeting solid tumors (ERAS-0015) and that a patient died one month
More news about: Hagens Berman Sobol Shapiro LLP
Jun 18, 2026, 10:07 ET ERAS Shareholder Alert: Erasca, Inc. Securities Class Action Lawsuit - Investors Should Contact SueWallSt
hundreds of millions of dollars for investors.Frequently Asked Questions About the ERAS LawsuitQ: Who is eligible to join the ERAS investor lawsuit? A: Investors who purchased ERAS stock or securities between January 14, 2025 and April 26, 2026 and suffered financial losses
More news about: SueWallSt.com
Jun 18, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Erasca, Inc. of Class Action Lawsuit and Upcoming Deadlines - ERAS
market hours on April 27, 2026, Erasca reported preliminary Phase 1 clinical data for ERAS-0015 and disclosing that one patient that received 24 mg of ERAS-0015 had died approximately a month after starting ERAS-0015. The patient was classified as a "Grade 3 TRAE of pneumonitis" that "progressed to Grade
More news about: Pomerantz LLP
Jun 17, 2026, 10:13 ET ERAS DEADLINE: Levi & Korsinsky Reminds Erasca, Inc. Investors of Upcoming Securities Class Action Deadline
filed by August 10, 2026.Frequently Asked Questions About the ERAS LawsuitQ: What is the ERAS class action lawsuit about? A: A securities class action has been filed against Erasca, Inc. (NASDAQ: ERAS) alleging materially false and misleading statements between January 14,
More news about: Levi & Korsinsky, LLP
Jun 17, 2026, 08:00 ET INVESTOR DEADLINE: Erasca, Inc. (ERAS) Investors with Substantial Losses Have Opportunity to Lead the Erasca Class Action Lawsuit
reported preliminary Phase I clinical data for ERAS-0015 and disclosed that one patient who received 24 mg of ERAS-0015 had died approximately one month after starting ERAS-0015. Erasca allegedly further disclosed that comparisons between ERAS-0015 and other product candidates were based
More news about: Robbins Geller Rudman & Dowd LLP